 |
answer text |
<p>Medical Research Council (MRC) has invested in research into Myalgic Encephalomyelitis/Chronic
Fatigue Syndrome (ME/CFS) for many years, awarding £6.6m in this area since 2012.
This includes through DecodeME, the world’s largest ME/CSF study, via strategic co-funding
with the National Institute of Health and Care Research, which aims to find genetic
factors to better understand ME/CFS disease pathways and unlock future treatment pathways.</p><p>
</p><p>We continue to encourage high-quality proposals across our funding opportunities,
maintaining an open highlight notice to encourage ME/CFS research. MRC also co-funded
the ME/CFS Priority Setting Partnership to identify research priorities for ME/CFS,
led by people with ME/CFS, their carers and clinicians, and facilitated by Action
for M.E.</p>
|
 |
